雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Hiroki Yamada 1 , Hajime Onuma 1 , Mariko Honda 1 , Isamu Kingetsu 2 , Hiroshi Kiyota 1 , Shin Egawa 3 Keyword: 腎盂癌 , 免疫チェックポイント阻害薬 pp.331-335
Published Date 2020/4/20
DOI https://doi.org/10.11477/mf.1413206917

Abstract

Sixty-four-year old male he visited our hospital with the chief complaint of asymptomatic gross hematuria. Based on the diagnosis of the right renal pelvic cancer with lymph node metastasis, radical surgery and para-aortic lymph node dissection were performed after systemic chemotherapy. During follow-up after the adjuvant chemotherapy, the remaining inter arteriovenous lymph became enlarged, then anti-PD-1 antibody treatment was introduced. After 4th month of anti-PD-1 antibody treatment, multiple joint pain accompanied by joint swelling appeared and was diagnosed as rheumatoid arthritis. Anti-rheumatoid arthritis treatment has improved joint symptoms, and anti-PD-1 antibody treatment is still continued. There is no relapse of joints and symptoms as well. Immune checkpoint inhibitors are known to have a variety of immune related adverse events, that require prompt and appropriate action. Rheumatoid arthritis is rarely reported as an immune-related adverse event. Here we report this case with a review of the literature (Rinsho Hinyokika 74 : 331-335, 2020).


Copyright © 2020, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1332 印刷版ISSN 0385-2393 医学書院

関連文献

もっと見る

文献を共有